Chemical inhibitors of ZNF564 encompass a range of compounds that interfere with various signaling pathways and cellular processes to inhibit the functional activity of this protein. Staurosporine is a broad-spectrum kinase inhibitor that can impede the phosphorylation events necessary for ZNF564 activity, thus directly inhibiting its function. Similarly, Wortmannin and LY294002 both target the PI3K/AKT pathway, which is crucial for numerous cellular functions, including those that could regulate ZNF564 activity. By hindering this pathway, these inhibitors can compromise the regulatory effects on ZNF564, leading to its functional inhibition. Rapamycin, known for its mTOR inhibitory effects, can suppress the mTOR signaling pathway, which likely contributes to the regulation of ZNF564, thereby reducing its functional output within the cell.
Further addressing the inhibition of ZNF564, compounds like SB203580 and PD98059 target the MAPK pathway by inhibiting p38 and MEK, respectively. These inhibitors can interrupt the signaling cascade that may control stress responses or inflammatory processes influencing ZNF564's function. U0126 also inhibits MEK, thereby blocking ERK pathway activation, which can affect the functional state of ZNF564. SP600125, a JNK inhibitor, may disrupt JNK signaling that could be involved in regulating proteins that interact with or control ZNF564, leading to its inhibition. Y-27632, a ROCK inhibitor, can affect the organization of the cytoskeleton, potentially disrupting cellular processes essential for ZNF564's function. Brefeldin A, by inhibiting protein transport, can prevent the proper trafficking of components necessary for ZNF564 to exert its function. Thapsigargin disrupts calcium homeostasis, a vital element for regulatory processes or post-translational modifications of ZNF564, thus inhibiting it. Lastly, Alsterpaullone, a cyclin-dependent kinase inhibitor, can halt the phosphorylation processes necessary for ZNF564's function, thereby inhibiting its activity within the cell. Each of these chemicals can impede the functional activity of ZNF564 by targeting specific signaling pathways and cellular mechanisms that are necessary for its proper functioning.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
As a potent kinase inhibitor, Staurosporine can inhibit a broad range of protein kinases that may be crucial for ZNF564 function, particularly by inhibiting phosphorylation events that ZNF564 may require for its activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor that can hinder the PI3K/AKT pathway, which could be involved in the post-translational modification or the regulation of ZNF564, resulting in its functional inhibition. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Similar to Wortmannin, LY294002 is another PI3K inhibitor that can disrupt the PI3K/AKT signaling pathway, potentially impairing any regulatory effects this pathway has on ZNF564 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an mTOR inhibitor, Rapamycin can inhibit the mTOR pathway which is likely involved in the regulation of ZNF564, thus diminishing its functional capacity within the pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This compound inhibits p38 MAPK, which could play a role in stress responses or inflammatory processes that regulate ZNF564's function or stability, leading to its inhibition. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
By inhibiting MEK, PD98059 can prevent the activation of ERK, which may be necessary for the phosphorylation of targets that modulate ZNF564's activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is another MEK inhibitor that can block ERK pathway activation, potentially affecting the phosphorylation and function of ZNF564. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
As a JNK inhibitor, SP600125 can inhibit the JNK signaling pathway which might be involved in the regulation of transcription factors or other proteins that interact with ZNF564, leading to inhibition. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
This compound is a ROCK inhibitor that can disrupt cytoskeletal organization and may interfere with cellular processes that are essential for the function of ZNF564. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
By inhibiting protein transport, Brefeldin A can prevent the trafficking of cellular components that are necessary for ZNF564 to exert its function, thus inhibiting its activity. | ||||||